Press Releases

Press Releases

or

September 4, 2018
BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) CAMBRIDGE, Mass., and BEIJING, China, Sept. 04, 2018 (GLOBE NEWSWIRE) --  BeiGene, Ltd.  (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative
August 9, 2018
BeiGene Reports Second Quarter 2018 Financial Results CAMBRIDGE, Mass. and BEIJING, China, Aug. 09, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and